GLP-1RAs did, however, significantly reduce the risk for new-onset MACE, MI, heart failure, and ischemic stroke in patients with AD and type 2 diabetes, suggesting that the benefit of GLP-1RAs is in diabetes vs atopic dermatitis
doi: 10.3389/fphar.2026.1736380 Received 10 November 2025 Revised 20 January 2026 Accepted 21 January 2026 Published 10 February 2026 Volume 17 - 2026 Edited by Madhusudan Prasad Singh, All India Institute of Medical Sciences Raipur, India Reviewed by Hemasri Velmurugan, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), India Prachi Arunima, All India Institute of Medical Sciences Raipur, India Updates Copyright 2026 Wali, Rangraze, Khan, Mufti, El-Tanani and Rizzo
A dosagem incorreta rotulada torna impossvel calcular uma exposio fivel
As shown in Scheme 11